S-1 review from preclinical pharmacology Masakazu Fukushima Review Article 05 February 2009 Pages: 3 - 9
Adjuvant chemotherapy with 5-FU or regimens including oral fluoropyrimidine for curable gastric cancer Mitsuru Sasako Review Article 05 February 2009 Pages: 10 - 15
Prediction of clinical outcome of S-1-based chemotherapy for gastric cancer patients Wataru IchikawaYasutsuna Sasaki Review Article 05 February 2009 Pages: 16 - 22
Combination chemotherapy of S-1 and taxanes in Korea Yeul Hong KimHoon-Kyo Kim Review Article 05 February 2009 Pages: 31 - 37
Phase I/II studies of combination chemotherapy with S-1 and platinum in patients with previously untreated metastatic or recurrent gastric cancer Yoon-Koo Kang Review Article 05 February 2009 Pages: 38 - 42
JCOG trials of systemic chemotherapy for unresectable or recurrent gastric cancer Narikazu Boku Review Article 05 February 2009 Pages: 43 - 49
Clinical development of S-1 plus cisplatin therapy as first-line treatment for advanced gastric cancer Wasaburo Koizumi Review Article 05 February 2009 Pages: 50 - 54
Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer Hiroya Takiuchi Review Article 05 February 2009 Pages: 55 - 59
Future perspectives of chemotherapy for advanced gastric cancer Atsushi OhtsuNozomu FuseToshihiko Doi Review Article 05 February 2009 Pages: 60 - 66